We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MannKind Told More Trials Needed for Afrezza Inhaler
MannKind Told More Trials Needed for Afrezza Inhaler
February 2, 2011
MannKind has received a second complete response letter for its inhaled insulin Afrezza requesting two new clinical trials to make up for what one analyst calls a “regulatory shortcut.”